Uni-Bio Science Group Limited — Capital/Financing Update 2013

May 8, 2013

Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement.

This announcement appears for information purposes only and does not constitute an invitation or offer to acquire, purchase or subscribe for the securities of the Company.

==> picture [316 x 59] intentionally omitted <==

(incorporated in the Cayman Islands with limited liability)

(stock code: 690)

COMPLETION OF PLACING OF NEW SHARES UNDER GENERAL MANDATE

Placing Agent

==> picture [47 x 36] intentionally omitted <==

Prominence Financials Limited

The Board is pleased to announce that an aggregate of 260,000,000 Placing Shares have been successfully placed at the Placing Price of HK$0.15 per Placing Share to not less than six independent institutional and professional investors, who and whose ultimate beneficial owners are independent of and not connected with the Company and its connected persons (as defined in the Listing Rules).

All the conditions of the Placing have been fulfilled and completion of the Placing took place on 8 May 2013. The Company received net proceeds of approximately HK$38 million from the Placing.

Reference is made to the announcement (“ Announcement ”) of the Company dated 19 April 2013 in relation to, among other things, the Placing of up to 260,000,000 new Shares. Unless otherwise defined herein, capitalised terms used in this announcement shall have the same meanings as those defined in the Announcement.

• For identification purpose only

– 1 –

The Board is pleased to announce that all the conditions of the Placing have been fulfilled and completion of the Placing took place on 8 May 2013. A total of 260,000,000 Placing Shares have been successfully placed at the Placing Price of HK$0.15 per Placing Share to not less than six independent institutional and professional investors.

To the best of the Director’s knowledge, information and belief having made all reasonable enquiries, each of the placees procured by the Placing Agent and where appropriate, its ultimate beneficial owners, is a third party independent of the Company and any director, chief executive or substantial shareholder of any member of the Group or any associate (as defined in the Listing Rules) of any of them or any connected persons of the Company.

The Placing Shares represent (i) approximately 19.93% of the issued share capital of the Company as at the date of Placing Agreement; and (ii) approximately 16.62% of the issued share capital of the Company as enlarged by the allotment and issue of the Placing Shares.

The net proceeds from the Placing are approximately HK$38 million. The Company plans to use the entire amount of such net proceeds for general working capital of the Group.

EFFECTS ON SHAREHOLDING STRUCTURE

The shareholding structure of the Company (i) immediately before completion of the Placing; and (ii) immediately after completion of the Placing are set out below:

Automatic Result Limited Note (1) The placees Overseas Capital Assets Limited Note (2) Other placees Other public Shareholders Total	Immediately before completion of the Placing No. of Shares % 302,918,844 23.21 – – – – 1,001,927,449 76.79 1,304,846,293 100.00	Immediately after completion of the Placing No. of Shares % 302,918,844 19.36 205,000,000 13.10 55,000,000 3.51 1,001,927,449 64.03 1,564,846,293 100.00	Immediately after completion of the Placing No. of Shares % 302,918,844 19.36 205,000,000 13.10 55,000,000 3.51 1,001,927,449 64.03 1,564,846,293 100.00
			100.00

– 2 –

Note:

• (1) Automatic Result Limited (“ Automatic Result ”) is solely and beneficially owned by Mr. Tong Kit Shing, whereas Mr. Liu Guoyao is the sole director of Automatic Result. Both Mr. Tong and Mr. Liu, each an executive Director, are deemed to be interested in the Shares held by Automatic Result by virtue of Part XV of the Securities and Futures Ordinance (Chapter 571 of the Laws of Hong Kong) (“ SFO ”).

• (2) Overseas Capital Assets Limited (“ Overseas Capital ”) is solely and beneficially owned by Mr. He Rufeng. Mr. He Rufeng is deemed to be interested in the Shares held by Overseas Capital by virtue of Part XV of the SFO.

On behalf of the Board Uni-Bio Science Group Limited Tong Kit Shing Chairman

Hong Kong, 8 May 2013

As at the date of this announcement, the executive Directors are Mr. TONG Kit Shing (Chairman), Mr. LIU Guoyao and Mr. LEUNG Ka Chun; the independent non-executive Directors are Mr. TSAO Hoi Ho, Terry, Mr. LOU Iok Kuong, Mr. NG Pak Kin, Danny and Mr. LEUNG Wai Chung, Vincent.

– 3 –